Trial intelligence / Profile preview

Dexmedetomidine vs Fentanyl in Major Abdominal Cancer Surgery

NCT07214714Phase 4Not yet recruiting

Sponsor
Assiut University
Start
Nov 2025
Primary completion
Nov 2026
Modality
Small Molecules
01

Overview

A Phase 4 trial of dexmedetomidine in Abdominal cancer, sponsored by Assiut University. Planned start Nov 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Abdominal cancer

Beyond the preview

Go deeper on NCT07214714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07214714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call